4//SEC Filing
Sank Leonard 4
Accession 0001213900-21-012894
CIK 0001176309other
Filed
Mar 1, 7:00 PM ET
Accepted
Mar 2, 4:12 PM ET
Size
8.3 KB
Accession
0001213900-21-012894
Insider Transaction Report
Form 4
Sank Leonard
Director
Transactions
- Other
Common Stock
2021-02-26$3.68/sh−78,125$287,500→ 0 total(indirect: By Trust) - Other
Common Stock
2021-02-26$3.68/sh−375,000$1,380,000→ 0 total(indirect: By Trust)
Holdings
- 138,889(indirect: By Trust)
Common Stock
Footnotes (3)
- [F1]The reported securities were transferred to the Ledo Investment Holdings Limited trust (the "Trust"), which is administered by an independent trustee for the benefit of the reporting person and his immediate family members. The reporting person disclaims beneficial ownership of the securities held by the Trust except to the extent of his pecuniary interest therein.
- [F2]Due to an administrative rounding error following the Issuer's 1-to-12 reverse stock split, which occurred on January 10, 2013, the Form 4 filed for the reporting person on February 11, 2013 inadvertently understated the amount of shares beneficially owned by the reporting person following the transaction by 1 share, which error has been corrected on this Form 4.
- [F3]These shares consist of shares of common stock owned by a company wholly owned by a trust of which the reporting person is a trustee. The reporting person disclaims beneficial ownership of these shares.
Documents
Issuer
ORAMED PHARMACEUTICALS INC.
CIK 0001176309
Entity typeother
Related Parties
1- filerCIK 0001416089
Filing Metadata
- Form type
- 4
- Filed
- Mar 1, 7:00 PM ET
- Accepted
- Mar 2, 4:12 PM ET
- Size
- 8.3 KB